Drug resistance mediated by AEG-1/MTDH/LYRIC

Advances in Cancer Research

Volumn 120, Issue , 2013, Pages 135-157

  Meng, Xiangbing ^a,b   Thiel, Kristina W ^a   Leslie, Kimberly K ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

AEG 1 MTDH LYRIC; Chemoresistance; MiR 375; NF B; SND1

Indexed keywords

ADENYLATE KINASE; ANTINEOPLASTIC AGENT; AUTOPHAGY PROTEIN 5; CISPLATIN; DOXORUBICIN; FLUOROURACIL; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MICRORNA; MITOMYCIN; MULTIDRUG RESISTANCE PROTEIN 1; NINTEDANIB; NUCLEASE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN AEG 1; PROTEIN KINASE B; PROTEIN LYRIC; PROTEIN MTDH; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; RNA BINDING PROTEIN; SELUMETINIB; TAMOXIFEN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; AUTOPHAGY; CANCER GROWTH; CARCINOGENESIS; GENE EXPRESSION; GENE SILENCING; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; ONCOGENE H RAS; ONCOGENE MYC; POLYSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AEG-1/MTDH/LYRIC; CHEMORESISTANCE; MIR-375; NFΚB; SND1;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CELL ADHESION MOLECULES; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MICROARRAY ANALYSIS; NEOPLASMS;

EID: 84880952481     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-401676-7.00005-X     Document Type: Chapter

References (82)

1. Ahmad A., Sakr W.A., Rahman K.M. Novel targets for detection of cancer and their modulation by chemopreventive natural compounds. Frontiers in Bioscience (Elite Edition) 2012, 4:410-425.
2. Bergamaschi A., Frasor J., Borgen K., Stanculescu A., Johnson P., Rowland K., et al. 14-3-3zeta as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers. Breast Cancer Research and Treatment 2013, 137:689-696.
3. Bergamaschi A., Katzenellenbogen B.S. Tamoxifen downregulation of miR-451 increases 14-3-3zeta and promotes breast cancer cell survival and endocrine resistance. Oncogene 2012, 31:39-47.
4. Bergamaschi A., Kim Y.H., Wang P., Sorlie T., Hernandez-Boussard T., Lonning P.E., et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes, Chromosomes & Cancer 2006, 45:1033-1040.
5. Bhutia S.K., Kegelman T.P., Das S.K., Azab B., Su Z.Z., Lee S.G., et al. Astrocyte elevated gene-1 induces protective autophagy. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:22243-22248.
6. Bierkens M., Krijgsman O., Wilting S.M., Bosch L., Jaspers A., Meijer G.A., et al. Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes, Chromosomes & Cancer 2013, 52:56-68.
7. Blanco M.A., Aleckovic M., Hua Y., Li T., Wei Y., Xu Z., et al. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. The Journal of Biological Chemistry 2011, 286:19982-19992.
8. Brown D.M., Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004, 5:365-374.
9. Camby I., Le Mercier M., Lefranc F., Kiss R. Galectin-1: A small protein with major functions. Glycobiology 2006, 16:137R-157R.
10. Chang C., Shi H., Wang C., Wang J., Geng N., Jiang X., et al. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma. Neuroscience Letters 2012, 531:204-208.
11. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genetics 2008, 40:43-50.
12. Chen Z.S., Tiwari A.K. Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases. The FEBS Journal 2011, 278:3226-3245.
13. Chen M., Zhang J., Manley J.L. Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Research 2010, 70:8977-8980.
14. Cieply B., Riley P., Pifer P.M., Widmeyer J., Addison J.B., Ivanov A.V., et al. Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2. Cancer Research 2012, 72:2440-2453.
15. Dai X., Chiang Y., Wang Z., Song Y., Lu C., Gao P., et al. Expression levels of microRNA-375 in colorectal carcinoma. Molecular Medicine Reports 2012, 5:1299-1304.
16. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., et al. A quantitative atlas of mitotic phosphorylation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:10762-10767.
17. Dompe N., Rivers C.S., Li L., Cordes S., Schwickart M., Punnoose E.A., et al. A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:E943-E951.
18. Emdad L., Lee S.G., Su Z.Z., Jeon H.Y., Boukerche H., Sarkar D., et al. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:21300-21305.
19. Emdad L., Sarkar D., Su Z.Z., Randolph A., Boukerche H., Valerie K., et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis. Cancer Research 2006, 66:1509-1516.
20. Finnegan E.F., Pasquinelli A.E. MicroRNA biogenesis: Regulating the regulators. Critical Reviews in Biochemistry and Molecular Biology 2013, 48:51-68.
21. Galardi S., Mercatelli N., Farace M.G., Ciafre S.A. NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Research 2011, 39:3892-3902.
22. Grant T.J., Bishop J.A., Christadore L.M., Barot G., Chin H.G., Woodson S., et al. Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:4503-4508.
23. He X.X., Chang Y., Meng F.Y., Wang M.Y., Xie Q.H., Tang F., et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012, 31:3357-3369.
24. Holleman A., Chung I., Olsen R.R., Kwak B., Mizokami A., Saijo N., et al. miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene 2011, 30:4386-4398.
25. Holoch P.A., Griffith T.S. TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies. European Journal of Pharmacology 2009, 625:63-72.
26. Hu G., Chong R.A., Yang Q., Wei Y., Blanco M.A., Li F., et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009, 15:9-20.
27. Hu G., Wei Y., Kang Y. The multifaceted role of MTDH/AEG-1 in cancer progression. Clinical Cancer Research 2009, 15:5615-5620.
28. Isozaki Y., Hoshino I., Nohata N., Kinoshita T., Akutsu Y., Hanari N., et al. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. International Journal of Oncology 2012, 41:985-994.
29. Kang D.C., Su Z.Z., Sarkar D., Emdad L., Volsky D.J., Fisher P.B. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005, 353:8-15.
30. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007, 26:7647-7655.
31. Kinoshita T., Hanazawa T., Nohata N., Okamoto Y., Seki N. The functional significance of microRNA-375 in human squamous cell carcinoma: Aberrant expression and effects on cancer pathways. Journal of Human Genetics 2012, 57:556-563.
32. Kong X., Moran M.S., Zhao Y., Yang Q. Inhibition of metadherin sensitizes breast cancer cells to AZD6244. Cancer Biology & Therapy 2012, 13:43-49.
33. Lee S.G., Jeon H.Y., Su Z.Z., Richards J.E., Vozhilla N., Sarkar D., et al. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 2009, 28:2476-2484.
34. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Franke T.F., Fisher P.B. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2008, 27:1114-1121.
35. Leverson J.D., Koskinen P.J., Orrico F.C., Rainio E.M., Jalkanen K.J., Dash A.B., et al. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Molecular Cell 1998, 2:417-425.
36. Li Y., Jiang Q., Xia N., Yang H., Hu C. Decreased expression of MicroRNA-375 in nonsmall cell lung cancer and its clinical significance. The Journal of International Medical Research 2012, 40:1662-1669.
37. Li C., Li R., Song H., Wang D., Feng T., Yu X., et al. Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer. Journal of Surgical Oncology 2011, 103:184-192.
38. Li C., Li Y., Wang X., Wang Z., Cai J., Wang L., et al. Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma. Histopathology 2012, 60:953-963.
39. Li L., Wei X.H., Pan Y.P., Li H.C., Yang H., He Q.H., et al. LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling. Oncogene 2010, 29:5785-5795.
40. Li Y., Zhang Q., Tian R., Wang Q., Zhao J.J., Iglehart J.D., et al. Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells. Cancer Research 2011, 71:7481-7489.
41. Li Y., Zou L., Li Q., Haibe-Kains B., Tian R., Desmedt C., et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nature Medicine 2010, 16:214-218.
42. Liu S., Guo W., Shi J., Li N., Yu X., Xue J., et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. Journal of Hepatology 2012, 56:389-396.
43. Liu H., Song X., Liu C., Xie L., Wei L., Sun R. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. Journal of Experimental & Clinical Cancer Research 2009, 28:19.
44. Lu L., Schwartz P., Scarampi L., Rutherford T., Canuto E.M., Yu H., et al. MicroRNA let-7a: A potential marker for selection of paclitaxel in ovarian cancer management. Gynecologic Oncology 2011, 122:366-371.
45. Lum J.J., Bauer D.E., Kong M., Harris M.H., Li C., Lindsten T., et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005, 120:237-248.
46. Meng X., Brachova P., Yang S., Xiong Z., Zhang Y., Thiel K.W., et al. Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment. PLoS one 2011, 6:e20920.
47. Meng F., Luo C., Ma L., Hu Y., Lou G. Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma. International Journal of Gynecological Pathology 2011, 30:145-150.
48. Meng X., Zhu D., Yang S., Wang X., Xiong Z., Zhang Y., et al. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein. The Journal of Biological Chemistry 2012, 287:4485-4491.
49. Murata T., Takayama K., Urano T., Fujimura T., Ashikari D., Obinata D., et al. 14-3-3zeta, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival. Clinical Cancer Research 2012, 18:5617-5627.
50. Nestal de Moraes G., Souza P.S., Costas F.C., Vasconcelos F.C., Reis F.R., Maia R.C. The interface between BCR-ABL-dependent and -independent resistance signaling pathways in chronic myeloid leukemia. Leukemia Research and Treatment 2012, 2012:671702.
51. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Sakurai D., Fujimura L., et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). Journal of Human Genetics 2011, 56:595-601.
52. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
53. Poon T.C., Wong N., Lai P.B., Rattray M., Johnson P.J., Sung J.J. A tumor progression model for hepatocellular carcinoma: Bioinformatic analysis of genomic data. Gastroenterology 2006, 131:1262-1270.
54. Qian B.J., Yan F., Li N., Liu Q.L., Lin Y.H., Liu C.M., et al. MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer. Cancer Immunology, Immunotherapy 2011, 60:883-893.
55. Rodriguez Lajusticia L., Martin Jimenez M., Lopez-Tarruella Cobo S. Endocrine therapy of metastatic breast cancer. Clinical & Translational Oncology 2008, 10:462-467.
56. Santhekadur P.K., Das S.K., Gredler R., Chen D., Srivastava J., Robertson C., et al. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor kappaB and miR-221. The Journal of Biological Chemistry 2012, 287:13952-13958.
57. Sarkar D., Park E.S., Emdad L., Lee S.G., Su Z.Z., Fisher P.B. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Research 2008, 68:1478-1484.
58. Sinha P., Kohl S., Fischer J., Hutter G., Kern M., Kottgen E., et al. Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis 2000, 21:3048-3057.
59. Srivastava J., Siddiq A., Emdad L., Santhekadur P.K., Chen D., Gredler R., et al. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: Novel insights from a mouse model. Hepatology 2012, 56:1782-1791.
60. Sun S., Li F., Gao X., Zhu Y., Chen J., Zhu X., et al. Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway. Neuroscience 2011, 199:359-367.
61. Tamada M., Suematsu M., Saya H. Pyruvate kinase m2: Multiple faces for conferring benefits on cancer cells. Clinical Cancer Research 2012, 18:5554-5561.
62. Thirkettle H.J., Girling J., Warren A.Y., Mills I.G., Sahadevan K., Leung H., et al. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clinical Cancer Research 2009, 15:3003-3013.
63. Thirkettle H.J., Mills I.G., Whitaker H.C., Neal D.E. Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression. Oncogene 2009, 28:3663-3670.
64. Tokunaga E., Nakashima Y., Yamashita N., Hisamatsu Y., Okada S., Akiyoshi S., et al. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer. Breast Cancer 2012, 10.1007/s12282-012-0398-2.
65. Totary-Jain H., Sanoudou D., Ben-Dov I.Z., Dautriche C.N., Guarnieri P., Marx S.O., et al. Reprogramming of the microRNA transcriptome mediates resistance to rapamycin. The Journal of Biological Chemistry 2013, 288:6034-6044.
66. Unsworth H., Raguz S., Edwards H.J., Higgins C.F., Yague E. mRNA escape from stress granule sequestration is dictated by localization to the endoplasmic reticulum. The FASEB Journal 2010, 24:3370-3380.
67. Valineva T., Yang J., Palovuori R., Silvennoinen O. The transcriptional co-activator protein p100 recruits histone acetyltransferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. The Journal of Biological Chemistry 2005, 280:14989-14996.
68. Vazquez A., Grochola L.F., Bond E.E., Levine A.J., Taubert H., Muller T.H., et al. Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival. Cancer Research 2010, 70:172-180.
69. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., Kubin M., et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Medicine 1999, 5:157-163.
70. Wang C., Yang Q. Astrocyte elevated gene-1 and breast cancer (Review). Oncology Letters 2011, 2:399-405.
71. Ward A., Balwierz A., Zhang J.D., Kublbeck M., Pawitan Y., Hielscher T., et al. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 2012, 32:1173-1182.
72. Weissbach R., Scadden A.D. Tudor-SN and ADAR1 are components of cytoplasmic stress granules. RNA 2012, 18:462-471.
73. Wilson M.S., Brosens J.J., Schwenen H.D., Lam E.W. FOXO and FOXM1 in cancer: The FOXO-FOXM1 axis shapes the outcome of cancer chemotherapy. Current Drug Targets 2011, 12:1256-1266.
74. Ying Z., Li J., Li M. Astrocyte elevated gene 1: Biological functions and molecular mechanism in cancer and beyond. Cell & Bioscience 2011, 1:36.
75. Yoo B.K., Chen D., Su Z.Z., Gredler R., Yoo J., Shah K., et al. Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Research 2010, 70:3249-3258.
76. Yoo B.K., Emdad L., Lee S.G., Su Z.Z., Santhekadur P., Chen D., et al. Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology. Pharmacology & Therapeutics 2011, 130:1-8.
77. Yoo B.K., Emdad L., Su Z.Z., Villanueva A., Chiang D.Y., Mukhopadhyay N.D., et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. The Journal of Clinical Investigation 2009, 119:465-477.
78. Yoo B.K., Gredler R., Chen D., Santhekadur P.K., Fisher P.B., Sarkar D. c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF. Journal of Hepatology 2011, 55:1317-1324.
79. Yoo B.K., Gredler R., Vozhilla N., Su Z.Z., Chen D., Forcier T., et al. Identification of genes conferring resistance to 5-fluorouracil. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:12938-12943.
80. Yoo B.K., Santhekadur P.K., Gredler R., Chen D., Emdad L., Bhutia S., et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 2011, 53:1538-1548.
81. Yuan C., Li X., Yan S., Yang Q., Liu X., Kong B. The MTDH (-470G>A) polymorphism is associated with ovarian cancer susceptibility. PLoS one 2012, 7:e51561.
82. Zhao Y., Moran M.S., Yang Q., Liu Q., Yuan C., Hong S., et al. Metadherin regulates radioresistance in cervical cancer cells. Oncology Reports 2012, 27:1520-1526.